The State of Texas Top Legal Officer Takes Legal Action Against Tylenol Makers Concerning Autism Spectrum Allegations

Texas Attorney General Ken Paxton is filing a lawsuit against the makers of Tylenol, claiming the firms concealed safety concerns that the pain reliever posed to pediatric neurological development.

The lawsuit arrives thirty days after Donald Trump advocated an unsubstantiated connection between consuming Tylenol - also known as acetaminophen - throughout gestation and autism spectrum disorder in offspring.

Paxton is suing the pharmaceutical giant, which once produced the medication, the only pain reliever suggested for women during pregnancy, and Kenvue, which currently produces it.

In a statement, he claimed they "misled consumers by profiting off of suffering and promoting medication without regard for the potential hazards."

The company states there is insufficient reliable data tying Tylenol to autism.

"These companies misled for generations, intentionally threatening numerous people to line their pockets," the attorney general, from the Republican party, declared.

The company said in a statement that it was "seriously troubled by the perpetuation of misinformation on the safety of acetaminophen and the potential impact that could have on the well-being of US mothers and children."

On its online platform, the company also stated it had "consistently assessed the applicable studies and there is insufficient valid information that demonstrates a verified association between using acetaminophen and autism spectrum disorder."

Organizations acting on behalf of physicians and healthcare providers share this view.

The leading OB-GYN organization has declared acetaminophen - the main ingredient in Tylenol - is one of the few options for pregnant women to address discomfort and elevated temperature, which can pose serious health risks if not addressed.

"In multiple decades of research on the consumption of paracetamol in gestation, not a single reputable study has conclusively proven that the use of paracetamol in any period of pregnancy leads to neurodevelopmental disorders in young ones," the association commented.

The lawsuit mentions latest statements from the previous government in arguing the drug is potentially dangerous.

Last month, Trump generated worry from health experts when he told women during pregnancy to "resist strongly" not to use acetaminophen when unwell.

The FDA then published an announcement that doctors should contemplate reducing the consumption of acetaminophen, while also stating that "a causal relationship" between the drug and autism spectrum disorder in children has remains unverified.

The Health Department head RFK Jr, who manages the FDA, had promised in April to initiate "extensive scientific investigation" that would determine the origin of autism spectrum disorder in a matter of months.

But authorities warned that identifying a single cause of autism spectrum disorder - believed by scientists to be the outcome of a complicated interplay of inherited and external influences - would not be simple.

Autism spectrum disorder is a category of enduring cognitive variation and condition that impacts how individuals perceive and engage with the surroundings, and is identified using doctors' observations.

In his lawsuit, the attorney general - aligned with the former president who is seeking federal office - alleges Kenvue and Johnson & Johnson "deliberately disregarded and sought to suppress the science" around acetaminophen and autism spectrum disorder.

The lawsuit aims to force the companies "destroy any promotional materials" that asserts acetaminophen is safe for expectant mothers.

The Texas lawsuit parallels the complaints of a assembly of parents of minors with autism and attention deficit hyperactivity disorder who sued the manufacturers of acetaminophen in 2022.

A federal judge threw out the lawsuit, declaring investigations from the family's specialists was inconclusive.